Galapagos NV (GLPG)
29.42
-0.34
(-1.14%)
USD |
NASDAQ |
Apr 02, 16:00
29.50
+0.08
(+0.27%)
After-Hours: 20:00
Galapagos EPS Diluted (Quarterly) : 13.81 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.742 |
| UCB SA | -- |
| Celyad Oncology SA | -- |
| Fagron NV | -- |
| AgomAb Therapeutics NV | -0.2568 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 910.76M |
| Revenue (Quarterly) | 1.048B |
| Total Expenses (Quarterly) | 137.73M |
| Enterprise Value | -1.574B |
| Gross Profit Margin (Quarterly) | 99.95% |
| Profit Margin (Quarterly) | 86.86% |
| Earnings Yield | 20.26% |
| Operating Earnings Yield | 29.24% |
| Normalized Earnings Yield | 29.88 |